Psychotic disorder and Breast cancer

Summary:

Breast cancer is found among people with Psychotic disorder, especially for people who are female, 50-59 old.

The study analyzes which people have Breast cancer with Psychotic disorder. It is created by eHealthMe based on reports of 51 people who have Psychotic disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Psychotic disorder?

Psychotic disorder is found to be associated with 1,232 drugs and 1,472 conditions by eHealthMe. Check the latest studies of Psychotic disorder.

What is Breast cancer?

Breast cancer is found to be associated with 1,295 drugs and 1,665 conditions by eHealthMe. Check the latest studies of Breast cancer.

On Jul, 04, 2026

51 people who have Psychotic Disorder and Breast Cancer are studied.

Would you have Breast cancer when you have Psychotic disorder?

Gender of people who have Psychotic Disorder and experienced Breast Cancer *:

female: 95.83 %
male: 4.17 %

Age of people who have Psychotic Disorder and experienced Breast Cancer *:

Common co-existing conditions for these people *:

High Blood Pressure: 12 people, 23.53%
Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 11 people, 21.57%
Sinusitis (inflammation of sinus): 10 people, 19.61%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 19.61%
Osteoporosis (bones weak and more likely to break): 10 people, 19.61%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 9 people, 17.65%
Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 8 people, 15.69%
Arthropathy: 2 people, 3.92%
Sleep Disorder: 2 people, 3.92%
High Blood Cholesterol: 2 people, 3.92%

Common drugs taken by these people *:

Common symptoms for these people *:

Malaise (a feeling of general discomfort or uneasiness): 11 people, 21.57%
White Blood Cell Count Decreased: 10 people, 19.61%
Lymphocyte Count Decreased: 9 people, 17.65%
Metastases To Lung (cancer spreads to lung): 9 people, 17.65%
Metastases To Liver (cancer spreads to liver): 9 people, 17.65%
Red Blood Cell Count Decreased: 9 people, 17.65%
Metastases To Bone (cancer spreads to bone): 9 people, 17.65%
White Blood Cell Count Increased: 9 people, 17.65%
Haemoglobin Decreased: 9 people, 17.65%
Haematocrit Decreased: 9 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Breast cancer?

- Check whether Breast cancer is associated with a drug or a condition

Related publications that referenced our studies

Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .

Related studies:

Treatments, associated drugs and conditions:

Psychotic disorder (61,342 reports)
Breast cancer (266,434 reports)

All the drugs that are associated with Breast cancer:

Breast cancer (1,295 drugs)

All the conditions that are associated with Breast cancer:

Breast cancer (1,665 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Breast cancer and Psychotic disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.